Ran Frenkel, Chief Development Operations Officer at Karyopharm Therapeutics Inc. (KPTI), sold 3,309 shares at $10.06 ($33K) on 2016-11-14, disclosed to the SEC on 2016-11-15.
Open-market sale of $33k KPTI by Chief Development Operations Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2022-02-09 | $20K | — | Filing → |
| KPTI | SELL | 2021-02-22 | $43K | — | Filing → |
| KPTI | SELL | 2021-02-17 | $32K | — | Filing → |